Table 3.
CNS Medication Class |
Controls, n = 1,264 |
Cases, n = 316 |
P-Value1 |
---|---|---|---|
Mean±Standard Deviation, Median (Interquartile Range) | |||
Antidepressant (serotonin norepinephrine reuptake inhibitor, selective serotonin reuptake inhibitor, tricyclic antidepressant) | 0.88 ± 1.51, 0 (0–1.50) | 0.81 ± 1.36, 0 (0–1.58) | .46 |
Antiepileptic | 0.25 ± 0.60, 0 (0–0) | 0.24 ± 0.56, 0 (0–0) | .78 |
Antipsychotic | 0.74 ± 2.59, 0 (0–0) | 1.02 ± 4.62, 0 (0–0.25) | .16 |
Benzodiazepine receptor agonist | 0.36 ± 1.47, 0 (0–0) | 0.34 ± 1.07, 0 (0–0) | .83 |
Opioids receptor agonists | 1.08 ± 3.22, 0 (0–0.67) | 1.99 ± 5.13, 0.11 (0–2.0) | <.001 |
All CNS medications | 3.32 ± 4.97, 1.91 (0.25–4.01) | 4.41 ± 7.25, 2.50 (0.50–5.75) | .002 |
Conditional logistic regression model